Nicox’s Post

🌟 An Innovator in Medical Technology 🌟 🎙️ I recently had the privilege of tuning into an enlightening episode featuring Lishan Aklog, MD, the visionary CEO of Lucid Diagnostics and a key figure at PAVmed Inc. and Veris Health. Here are some captivating takeaways from his journey: 1️⃣ From Heart Surgery to Health Tech: Dr. Aklog’s transition from a renowned cardiothoracic surgeon to a medical technology innovator is truly inspiring. His passion for technological advancements in medicine has led to significant contributions in the field. 2️⃣ Entrepreneurial Leap: Dr. Aklog’s venture into entrepreneurship led to the founding of Lucid Diagnostics and PAVmed. His journey highlights the power of innovation in transforming healthcare. 3️⃣ A Crusade Against Cancer: Under his leadership, Lucid Diagnostics focuses on early cancer detection, particularly esophageal cancer. Dr. Aklog emphasizes the critical role of pre-cancer detection in saving lives. 4️⃣ Overcoming Challenges: Dr. Aklog candidly shared the challenges of raising capital and bringing new technologies to market. His perseverance and success are a testament to his dedication and skill. 5️⃣ Leadership with Purpose: At the heart of Dr. Aklog’s philosophy is a culture of teamwork, innovation, and a relentless drive to impact patient care positively. 👏 His story is not just about medical advancements but also about the human spirit's resilience and the desire to make a difference. This is truly an episode packed with valuable lessons for anyone in the healthcare industry or aspiring to make an impact through innovation. #HealthcareInnovation #Leadership #MedicalTechnology #CancerPrevention #Entrepreneurship #LucidDiagnostics #Inspiration

CS Genetics Announces Leadership Promotions: Jay Harger, PhD, Named COO, and Mike Stubbington, PhD, Appointed CSO Learn more & get our take 👇 https://lnkd.in/gH-8t94Q “Mike and Jay’s leadership will be catalytic as we shift attention to our commercial launch. Their promotions are hugely well-deserved, and their leadership in these new roles will continue to be catalytic as we now shift attention to our first commercial launch.” — Lucas Edelman, Founder, Board Member, and CTO at CS Genetics #genetics #leadership #SoHCNews

In one of his last CEO group meetings, 30-year Vistage member, John Myrna sought help from his peers after a courageous battle with cancer. This profound discussion highlights John's life, legacy, the impact the Vistage community had on him, and the impact John had on his peers. Read more about John's incredible journey and legacy. #Vistage #StrategicPlanning #Leadership #Legacy

🎧 Listen to the latest Front Lines podcast on Category Visionaries! 🚀 Join our CEO & Co-Founder Claudius Jehle as he shares insights on our innovative battery diagnostics platform. 𝗧𝗼𝗽 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀: - Pioneering battery diagnostics technology - Real-time battery data analysis algorithms - Global monitoring of many 10,000 battery units - Strategic early adopters through industry events - API-based integrations for scalable deployment Don't miss this episode full of expert advice and inspiring stories! 👉🏻 Listen here: https://lnkd.in/e-dXFAwH #BatteryDiagnostics #TechInnovation #Podcast #CategoryVisionaries #volytica

2024 was mean to be an ordinary year, focused on continuing to rapidly execute what we’ve been building at ✨Orum.io ✨ to transform payment technology for businesses. But the universe had other plans and when I learned I was facing genetically linked early stage #breastcancer suddenly there were way more questions than there were answers. There hasn’t been a playbook for founders who are facing unexpected medical leave, so I had to write my own. It was an honor to work with Christine Haughney Dare-Bryan and Inc. Magazine to share my 5 biggest leadership lessons….. ones I hope others can easily put into practice. #fintech #founders #startup

As part of the MODEL (Mentorship, Opportunity, Development, Empowerment, Leadership) Program launched by the Department of Medicine in Jan. 2024, #StanDOM's Wen-Kai Weng is making significant strides in supporting our CE and UML faculty. His leadership exemplifies the core values of mentorship and empowerment. Read more about Wen-Kai's journey and impact! #MODELProgram #Mentorship https://lnkd.in/eNmNFrCy 

Delighted to announce the final close of our Series A Extension financing at $6.18M (CHF 5.65M)! Led by new lead investor, the Corporate Venture Capital arm of Topcon Healthcare, the round also brought in Zürcher Kantonalbank (ZKB) together with existing Series A and seed investors the btoventures Industrial Technologies fund, managed by Matterwave Ventures, Verve Ventures and private investors. This brings to $11.66M (CHF 10.66M) the total equity raised. As part of the financing, and to facilitate our evolution and growth, we have concluded our corporate restructuring: RetinAI Medical AG is rebranded as Ikerian AG, with a wholly-owned subsidiary RetinAI U.S. Inc. (Retinai) focused on the ophthalmology market. The new funds will support continued development and commercial roll out of RetinAI Discovery® in #ophthalmology and #optometry and for Ikerian's expansion into new therapeutic areas prioritizing neurodegenerative disorders, vascular conditions and rare diseases. Red the full press release here – https://lnkd.in/gxW54UEu #machinelearning #eyecare #healthcare #clinicalstudies #screening #prescreening #generativeAI #pharmaceuticalresearch #clinicaldevelopment #artificialintelligence #AI #startup #financing #seriesA #opthalmology #healthtech

🆕 𝐆𝐢𝐥𝐝𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐜𝐨-𝐥𝐞𝐚𝐝𝐬 𝐨𝐯𝐞𝐫𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞𝐝 €𝟓𝟒 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐒𝐞𝐫𝐢𝐞𝐬 𝐁 𝐫𝐨𝐮𝐧𝐝 𝐨𝐟 𝐀𝐫𝐠𝐚́ 𝐌𝐞𝐝𝐭𝐞𝐜𝐡 Argá Medtech SA, a company developing a next-generation #cardiacablation system for treating cardiac #arrhythmias, including #atrialfibrillation (AF), announced it closed a €54M oversubscribed Series B raise co-led by Gilde Healthcare with existing investors, Advent Life Sciences and Earlybird Venture Capital, as well as an undisclosed strategic investor. The financing enables Argá Medtech to advance the development of its innovative Pulsed Field Ablation (PFA) system for treating AF through the execution of an IDE study in the US and a CE Mark study in the EU. Read more: https://lnkd.in/dHPSSB-B #digitalhealth #healthinnovation

📈 ViaLase, Inc., a clinical-stage #medicaltechnology company focused on addressing unmet needs in glaucoma treatment, closed a Series C financing raising gross proceeds of approximately $40 million. The financing was led by a new investor along with support from current investors, including Venture Investors Health Fund, Arboretum Ventures and Falcon Vision, an ophthalmology investment platform supported by KKR. Proceeds from this round of financing will ensure the continued advancement of clinical, regulatory, and commercial milestones of the Company’s ViaLase Laser and help the company move to the —commercialisation stage. 👏 We wish CEO Tibor Juhasz, COO Hadi Srass, Director International Technical Operations Adam Porter, and the rest of the team best of luck in their future work. 🔗 https://lnkd.in/eDdu6gKZ #MedicalDevices #MedicalDevice #MedicalEquipment #Medicine #TechNews #Funding #MedTechFunding #FundingRound #ClinicalStudy #AngelInvestment #GSCapitalConnect